Skip to content

The Use of plasmaJet During Operative Laparoscopy for Endometriosis

The Use of plasmaJet During Operative Laparoscopy for Endometriosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04394468
Acronym
PLASMA
Enrollment
23
Registered
2020-05-19
Start date
2020-02-07
Completion date
2021-12-31
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

Endometriosis is a condition where functional endometrial tissue is present outside the uterus. It usually locates in the pelvis, which often includes the ovaries. One of the main concerns when performing surgery is to maintain fertility. Nevertheless, a disadvantage of using monopolar and bipolar instruments for laparoscopic excision or coagulation of endometriosis lesions is the energy / thermal distribution that can cause damage to the surrounding healthy tissue. Therefore, the use of ultrasound, laser or plasma energy can potentially reduce damage to surrounding tissues and prevent adhesion formation. In addition, ablation of the internal surface of endometriomas can be an effective alternative to cystectomy. The PlasmaJet system uses argon plasma which is released as kinetic, light and / or thermal energy. In this way the instrument can be applied within three functions, namely cutting, vaporizing and coagulating. Moreover, plasma will dissipate very quickly upon contact with tissue which consequently allows a controlled depth of tissue penetration. Thirdly, pure plasma energy differs from conventional electrosurgery since no electrical current will be spread through the tissue and therefore the thermal effect at surrounding tissues remains minimal. The aim of this pilot study is to investigate the feasibility, effectiveness and safety of plasma energy in the treatment of endometriosis.

Interventions

DEVICEPlasmaJet

Data will be collected during two contact moments, in particular during her admission for surgical laparoscopy, and during her postoperative check-up. Both of these are standard of care. No additional questionnaires will be taken. During the admission the postoperative pain scoreswill be monitored and collected. The duration of her stay in the hospital will also be recorded. During the postoperative check-up, which takes usually place six weeks after the surgery, complications will registered.

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Women between 18 and 45 years old. * The presence of endometriosis; requiring surgical laparoscopy.

Exclusion criteria

* Women younger than 18 years. * Women older than 45 years. * Women who are scheduled for surgical laparoscopy where the removal of the uterus and / or ovaries is needed. * Women who do not give written permission to participate.

Design outcomes

Primary

MeasureTime frameDescription
feasibility of the PlasmaJet instrumentDuring laparoscopic surgeryThe surgeon's satisfaction with the use of plasma energy (5-point Likert scale).
effectiveness of the PlasmaJet instrumentDuring laparoscopic surgery\- Whether or not to use additional instruments to achieve hemostasis (monopolar or bipolar coagulation) and / or complete resection of the lesions (monopolar or ultrasonic energy).
safety of the PlasmaJet instrumentDuring laparoscopic surgery until six weeks after surgery\- Need for conversion to laparotomy.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026